IVD

3-Part Differential Analysers

Auto Haematology Analysers Mindray pride themselves on their dedication and experience in developing better solutions for small labs. their range of new 3-part haematology analysers is the culmination of that effort. It provides small labs with more confidence in results and less turnaround time.

Details
ABD PAD^®
Blood Group Test using M-TRAP^® Technology M-TRAP^® Technology is based on the detection of antigen-antibody interaction on a porous membrane. Only the red blood cells having the corresponding antigen are fixed into the membrane revealing immediately the reaction. A breakthrough technology! The principle: The M-TRAP® Technology, patented by DIAGAST, relies on the superposition of membranes and has 2 major advantages:

Since the test antibodies are inside the upper membrane, they never get in direct contact with the user. There is no risk of cross-contamination.

Since the lower membrane absorbs the liquids of the test (PAD Buffer and sample), the risk of blood exposure is considerably lower.

This simple protocol takes place in 3 steps and in 30 seconds.
Details
ABTest Card^®

Confirm ABO compatibility ABTest Card^® is a device, from Diagast, for the confirmation of ABO compatibility between the patient and the blood unit to be transfused. Based on the M-TRAP^® technology, it allows an easy and simple confirmation, safer for both user and patient. The red blood cells tested, carrying an antigen, interact with the related antibodies, revealing a red spot (positive reaction). The red blood cells that do not carry the antigen do not interact with the antibodies and cross the membrane. The spot will appear light green or white (negative reaction). If the red blood cells tested interact with the associated antibodies, the blood deposit remains. Red blood cells carry the desired antigens. It is a positive reaction. If the red blood cells tested do not interact with the associated antibodies, the blood deposit disappears. Red blood cells do not carry the desired antigens. It is a negative reaction. ABTest MULTI also offers a bedside test dedicated to emergency massive transfusions. This device allows to test once the patient to transfuse a maximum of 3 red blood cell (RBC) within 1 hour, allowing safety and traceability.

Details
AccuPlex™ Monkeypox Positive Reference Material Kit
On-going Performance Monitoring for Routine Patient Testing AccuPlex Monkeypox Positive Reference Material Kit is a full-process quality solution designed to challenge the molecular test procedure from extraction to detection, ensuring clinical laboratories can have confidence in their assay results. The product contains positive materials directed against targets for Monkeypox assays.
Non-infectious and replication deficient, enables safe handling in contrast to viral samples
Fully-extractable with a real viral protein coat; superior to “naked” transcribed RNA
Long shelf life: 2-year stability at 2 - 8°C
Details
AccuPlex™ SARS-CoV-2 Reference Material
SeraCare’s SARS-CoV-2 Quality Solution AccuPlex™ SARS-CoV-2 Reference Material, from SeraCare, is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. The product is available in versions that offer different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS‐CoV‐2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene. AccuPlex™ SARS-CoV-2 Verification Panel, coupled with the AccuPlex™ SARS-CoV-2 Reference Material, is a complete Quality Solution. Both products are available in three versions with different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS-CoV-2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene.
Non-infectious and replication deficient, enables safe handling of positive material
Fully-extractable with a real viral protein coat; serves as a full-process reference material
Compatible with assays targeting CDC and WHO consensus sequences
Includes negative reference material for targeting sequences for the human RNAse P gene
2 year stability at 2 - 8°C
Customisable to sequences of interest to meet unique assay design requirements
Details
AccuPlex™ SARS-CoV-2 Variant Panel 1
Clinical Diagnostic Quality Solutions for SARS-CoV-2 Variant Analysis AccuPlex SARS-CoV-2 Variant Panel 1 contains the full SARS-CoV-2 genomic RNA with a focus on S-gene mutations (Table 1) in three prominent variants of concern (VOC): UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1. The kit has one vial for each variant as well as a fourth wild type (reference sequence NC_045512) control vial. An RNase P negative control vial is also included.
Performance confirmation of existing SARS-CoV-2 molecular assays with different variants
Reference materials for SARS-CoV-2 variant genotyping assays
Reference materials for SARS-CoV-2 NGS assays
Non-infectious and replication deficient, enables safe handling of positive material
Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA
2 year stability at 2 - 8°C
Details
AccuPlex™ SARS-CoV-2 Verification Panel
Full Genome Coverage now available AccuPlex™ SARS-CoV-2 Verification Panel, from SeraCare, is optimised for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. The product contains positive materials including the full SARS-CoV-2 viral genome, and negative materials targeting the human RNase P gene. AccuPlex™ SARS-CoV-2 Verification Panel, coupled with the AccuPlex™ SARS-CoV-2 Reference Material, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their SARS-CoV-2 assay results.
Non-infectious and replication deficient, enables safe handling of positive material
Fully-extractable with a real viral protein coat; serves as a full-process reference material
Compatible with assays targeting CDC and WHO consensus sequences
Includes negative reference material for targeting sequences for the human RNAse P gene
2 year stability at 2 - 8°C
Customisable to sequences of interest to meet unique assay design requirements
Details
AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit
Measure day-to-day performance AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, from SeraCare, is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. Designed for use with multiplexed molecular assays that can detect SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV). AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, coupled with the AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their multiplex assay results.
Non-infectious and replication deficient, enables safe handling of positive material
Fully-extractable with a real viral protein coat; serves as a full-process reference material
2 year stability at 2 - 8°C
Optimised for assay verification and day-to-day performance monitoring
Details
AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel
Have confidence in your multiplex assay results for SARS-CoV-2 & Flu A/B AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, from SeraCare, is optimised for assay verification at installation by documenting test performance along the assay’s range, enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. Designed for use with multiplexed molecular assays that can detect SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV). AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel, coupled with the AccuPlex™ SARS-CoV-2, Flu A/B and RSV Reference Material Kit, is a complete Quality Solution designed to challenge the entire molecular test procedure ensuring clinical laboratories can have confidence in their multiplex assay results.
Non-infectious and replication deficient, enables safe handling of positive material
Fully-extractable with a real viral protein coat; serves as a full-process reference material
2 year stability at 2 - 8°C
Optimised for assay verification and day-to-day performance monitoring
Details
ACCURUN^® Anti-SARS-CoV-2 Reference Material Kit

Ensure antibody testing accuracy and performance To support the many SARS-CoV-2 serology assay formats available, the kit is currently offered in two configurations, one designed for IgG-specific assays and the other for total antibody tests. Series 1000 is released using the Abbott ARCHITECT SARS-CoV-2 IgG assay, and Series 2000 is released using the Roche cobas^® Elecsys^® Anti-SARS-CoV-2 assay. Reference materials are specifically formulated to exhibit low positive reactivity in true patient-like matrices, to test assay performance near critical signal cutoff boundaries. AccuSet™ SARS-CoV-2 Performance Panel is intended to provide an out-of-the-box solution to evaluate SARS-CoV-2 antibody detection assays with highly characterised human specimens whether generating validation data for a regulatory submission or performing assay verification in a clinical laboratory setting.

Details
ACCURUN^® Swab Strep A Reference Material Kit

Ensure Strep A Laboratory Testing Assay Performance ACCURUN^® reference materials are intended to estimate laboratory testing precision and can be used to detect errors in laboratory testing procedures. ACCURUN Swab Strep A Reference Material is formulated for use with molecular test methods used to detect Streptococcus pyogenes (Strep A). They are designed as whole organism reference materials that can be used to assess accuracy and performance of the full testing process – extraction, amplification, and detection – of molecular assays for Strep A. For Research Use Only. Not for use in diagnostic procedures.

Details
ACCURUN^® Molecular Controls & Reference Materials

Whole-cell or whole-organism external controls Empower your results and challenge your methods with SeraCare’s ACCURUN^® molecular controls and reference materials. ACCURUN molecular controls and reference materials are whole-cell or whole-organism external controls that help you monitor all aspects of your molecular testing methods and provide additional confidence in your laboratory test results. A well-designed QC program can help you avoid costly false-negative or false-positive results. ACCURUN molecular controls effectively detect low-positives closer to assay-specific cutoffs, enabling better detection of assay variability. Powerful ACCURUN controls and reference materials help to ensure complete control over assay performance monitoring. Monitors the Entire Testing Process. In order to execute the highest level of quality control, QC methods should be able to monitor the entire testing process, not just a portion. ACCURUN molecular controls are whole-cell or whole-organism controls that can appropriately challenge your assay from extraction through detection.

Details